Skip to main content
Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging 13/2023

03.08.2023 | Original Article

Feasibility of acquisitions using total-body PET/CT with a half-dose [68Ga]Ga-FAPI-04 activity in oncology patients

verfasst von: Zijun Chen, Yining Wang, Xinlan Yang, Lianghua Li, Yanmiao Huo, Xiaofeng Yu, Xiuying Xiao, Chenpeng Zhang, Yumei Chen, Haitao Zhao, Yun Zhou, Gang Huang, Jianjun Liu, Ruohua Chen

Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging | Ausgabe 13/2023

Einloggen, um Zugang zu erhalten

Abstract

Background

[68Ga]Ga-FAPI-04 (gallium-68-labeled fibroblast activation protein inhibitor-04) PET/CT has been widely used in diagnosing malignant tumors. Total-body PET/CT has a long axial field of view and provides higher sensitivity compared to traditional PET/CT. However, whether the reduced injected dose of [68Ga]Ga-FAPI-04 could obtain qualified imaging has not been evaluated.

Purpose

To explore the effect of half-dose [68Ga]Ga-FAPI-04 on image quality and tumor detectability in oncology patients.

Methods

A total of twenty-seven patients with tumors or clinically suspected tumors were included, and all patients were scanned with total-body PET/CT after an injected dose of 0.84–1.14 MBq/kg [68Ga]Ga-FAPI-04. All patients obtained superior image quality with 300 s original acquisition time. Images were reconstructed using 180 s, 120 s, 60 s, 40 s, 30 s, 20 s scanning duration by ordered subset expectation maximization algorithm. The subjective image quality of all patients in each time group was scored using 5-point Likert scale. Mediastinal blood pool, liver, spleen, and muscle were analyzed as background using semi-quantitative parameters maximum standardized uptake values (SUVmax), mean standardized uptake values (SUVmean), standard deviation (SD), and signal to noise ratio (SNR). The lesion detection rate, SUVmax, and tumor-to-background ratio (TBR) were calculated for tumors confirmed by pathology.

Results

The subjective image quality score decreased with the shortening of scanning time; however, both 180 s and 120 s images met the diagnostic requirements in terms of overall quality, lesion conspicuity, and image noise. The SUVmax of background increased with the reduction of scanning time, while the SUVmean was relatively stable. With the shortening of scanning time, the SD gradually increased, and the SNR gradually decreased, which was consistent with subjective image quality scores. In 180 s and 120 s images, all 11 primary lesions and 79 metastatic lesions were detected. The SUVmax of tumor focus showed an increasing trend as same as the background. Compared with 300 s, the TBR muscle had no statistical difference in 180 s and 120 s.

Conclusions

Half-dose [68Ga]Ga-FAPI-04 in total-body PET/CT imaging can shorten the acquisition time to 120 s with acceptable subjective image quality and 100% tumor detection rate. Total-body PET/CT imaging with a half-dose [68Ga]Ga-FAPI-04 and reduced acquisition time can be used in radiation-sensitive and poor tolerant to prolong horizontal positioning and waiting time populations such as children and gravidas.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
3.
Zurück zum Zitat Spencer BA, Berg E, Schmall JP, Omidvari N, Leung EK, Abdelhafez YG, et al. Performance evaluation of the uEXPLORER total-body PET/CT scanner based on NEMA NU 2-2018 with additional tests to characterize PET scanners with a long axial field of view. J Nucl Med : Official Public, Soc Nuclear Med. 2021;62:861–70. https://doi.org/10.2967/jnumed.120.250597.CrossRef Spencer BA, Berg E, Schmall JP, Omidvari N, Leung EK, Abdelhafez YG, et al. Performance evaluation of the uEXPLORER total-body PET/CT scanner based on NEMA NU 2-2018 with additional tests to characterize PET scanners with a long axial field of view. J Nucl Med : Official Public, Soc Nuclear Med. 2021;62:861–70. https://​doi.​org/​10.​2967/​jnumed.​120.​250597.CrossRef
5.
Zurück zum Zitat Mona CE, Benz MR, Hikmat F, Grogan TR, Lueckerath K, Razmaria A, et al. Correlation of (68)Ga-FAPi-46 PET biodistribution with FAP expression by immunohistochemistry in patients with solid cancers: interim analysis of a prospective translational exploratory study. J Nucl Med : Official Public, Soc Nucl Med. 2022;63:1021–6. https://doi.org/10.2967/jnumed.121.262426.CrossRef Mona CE, Benz MR, Hikmat F, Grogan TR, Lueckerath K, Razmaria A, et al. Correlation of (68)Ga-FAPi-46 PET biodistribution with FAP expression by immunohistochemistry in patients with solid cancers: interim analysis of a prospective translational exploratory study. J Nucl Med : Official Public, Soc Nucl Med. 2022;63:1021–6. https://​doi.​org/​10.​2967/​jnumed.​121.​262426.CrossRef
14.
Zurück zum Zitat Liu G, Hu P, Yu H, Tan H, Zhang Y, Yin H, et al. Ultra-low-activity total-body dynamic PET imaging allows equal performance to full-activity PET imaging for investigating kinetic metrics of (18)F-FDG in healthy volunteers. Eur J Nucl Med Molecul Imag. 2021;48:2373–83. https://doi.org/10.1007/s00259-020-05173-3.CrossRef Liu G, Hu P, Yu H, Tan H, Zhang Y, Yin H, et al. Ultra-low-activity total-body dynamic PET imaging allows equal performance to full-activity PET imaging for investigating kinetic metrics of (18)F-FDG in healthy volunteers. Eur J Nucl Med Molecul Imag. 2021;48:2373–83. https://​doi.​org/​10.​1007/​s00259-020-05173-3.CrossRef
20.
Zurück zum Zitat Zhu W, Cheng Y, Wang X, Yao S, Bai C, Zhao H, et al. Head-to-head comparison of (68)Ga-DOTA-JR11 and (68)Ga-DOTATATE PET/CT in patients with metastatic, well-differentiated neuroendocrine tumors: a prospective study. J Nucl Med : Official Public, Soc Nucl Med. 2020;61:897–903. https://doi.org/10.2967/jnumed.119.235093.CrossRef Zhu W, Cheng Y, Wang X, Yao S, Bai C, Zhao H, et al. Head-to-head comparison of (68)Ga-DOTA-JR11 and (68)Ga-DOTATATE PET/CT in patients with metastatic, well-differentiated neuroendocrine tumors: a prospective study. J Nucl Med : Official Public, Soc Nucl Med. 2020;61:897–903. https://​doi.​org/​10.​2967/​jnumed.​119.​235093.CrossRef
Metadaten
Titel
Feasibility of acquisitions using total-body PET/CT with a half-dose [68Ga]Ga-FAPI-04 activity in oncology patients
verfasst von
Zijun Chen
Yining Wang
Xinlan Yang
Lianghua Li
Yanmiao Huo
Xiaofeng Yu
Xiuying Xiao
Chenpeng Zhang
Yumei Chen
Haitao Zhao
Yun Zhou
Gang Huang
Jianjun Liu
Ruohua Chen
Publikationsdatum
03.08.2023
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Nuclear Medicine and Molecular Imaging / Ausgabe 13/2023
Print ISSN: 1619-7070
Elektronische ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-023-06354-6

Weitere Artikel der Ausgabe 13/2023

European Journal of Nuclear Medicine and Molecular Imaging 13/2023 Zur Ausgabe